SHR-3045

· Guangdong Hengrui Pharmaceutical Co., Ltd

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SHR-3045, covering 2025-08-12 to 2025-11-17. Get the full timeline:

Most recent: Clinical Trial Update: The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of SHR-3045 in Healthy Subjects [Phase 1]